Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Next-generation drug repurposing using human genetics and network biology
Serguei Nabirotchkin, Alex E. Peluffo, Philippe Rinaudo, et al.
Current Opinion in Pharmacology (2020) Vol. 51, pp. 78-92
Open Access | Times Cited: 75

Showing 1-25 of 75 citing articles:

Host genetics and infectious disease: new tools, insights and translational opportunities
Andrew Kwok, Alexander J. Mentzer, Julian C. Knight
Nature Reviews Genetics (2020) Vol. 22, Iss. 3, pp. 137-153
Open Access | Times Cited: 163
Advancing pharmacy and healthcare with virtual digital technologies
Sarah J. Trenfield, Atheer Awad, Laura E. McCoubrey, et al.
Advanced Drug Delivery Reviews (2022) Vol. 182, pp. 114098-114098
Open Access | Times Cited: 117
A Global Picture: Therapeutic Perspectives for COVID-19
Vivek P. Chavda, Carron Kapadia, Shailvi Soni, et al.
Immunotherapy (2022) Vol. 14, Iss. 5, pp. 351-371
Open Access | Times Cited: 70
Drug targets for COVID-19 therapeutics: Ongoing global efforts
Ambrish Saxena
Journal of Biosciences (2020) Vol. 45, Iss. 1
Open Access | Times Cited: 79
Network bioinformatics analysis provides insight into drug repurposing for COVID-19
Li Xu, Jinchao Yu, Zhiming Zhang, et al.
Medicine in Drug Discovery (2021) Vol. 10, pp. 100090-100090
Open Access | Times Cited: 78
Polygenic risk scores: An overview from bench to bedside for personalised medicine
Benjamin Cross, Richard Turner, Munir Pirmohamed
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 45
A Network Pharmacology Study and Experimental Validation to Identify the Potential Mechanism of Heparan Sulfate on Alzheimer’s Disease-Related Neuroinflammation
Dong-Uk Kim, Bitna Kweon, Jin Young Oh, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 103-103
Open Access
Personalized prediction of anticancer potential of non-oncology drugs through learning from genome derived molecular pathways
Xiaobao Dong, Huanhuan Liu, Ting Tong, et al.
npj Precision Oncology (2025) Vol. 9, Iss. 1
Open Access
Integrative Network Biology Framework Elucidates Molecular Mechanisms of SARS-CoV-2 Pathogenesis
Nilesh Kumar, Bharat Mishra, Adeel Mehmood, et al.
iScience (2020) Vol. 23, Iss. 9, pp. 101526-101526
Open Access | Times Cited: 59
Network analysis reveals rare disease signatures across multiple levels of biological organization
Pisanu Buphamalai, Tomislav Kokotović, Vanja Nagy, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 50
Machine learning, artificial intelligence, and data science breaking into drug design and neglected diseases
José Peña‐Guerrero, Paul Nguewa, Alfonso T. García‐Sosa
Wiley Interdisciplinary Reviews Computational Molecular Science (2021) Vol. 11, Iss. 5
Closed Access | Times Cited: 46
Current Pharmacological Strategies for Duchenne Muscular Dystrophy
Shanshan Yao, Zihao Chen, Liang Yu, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 45
Drug Development Strategies for Malaria: With the Hope for New Antimalarial Drug Discovery—An Update
Swaroop Kumar Pandey, Uttpal Anand, Waseem Ahmad Siddiqui, et al.
Advances in Medicine (2023) Vol. 2023, pp. 1-10
Open Access | Times Cited: 17
Drug development advances in human genetics‐based targets
X. Zhang, Wenjun Yu, Yan Li, et al.
MedComm (2024) Vol. 5, Iss. 2
Open Access | Times Cited: 5
Focusing on the Unfolded Protein Response and Autophagy Related Pathways to Reposition Common Approved Drugs against COVID-19
Serguei Nabirotchkin, Alex E. Peluffo, Jan Bouaziz, et al.
(2020)
Open Access | Times Cited: 47
Network Bioinformatics Analysis Provides Insight into Drug Repurposing for COVID-2019
Li Xu, Jinchao Yu, Zhiming Zhang, et al.
(2020)
Open Access | Times Cited: 45
Genomics insights of SARS-CoV-2 (COVID-19) into target-based drug discovery
P. Chellapandi, S. Saranya
Medicinal Chemistry Research (2020) Vol. 29, Iss. 10, pp. 1777-1791
Open Access | Times Cited: 45
Recent discoveries in HIV-1 reverse transcriptase inhibitors
Shuang‐Xi Gu, Yuan‐Yuan Zhu, Chao Wang, et al.
Current Opinion in Pharmacology (2020) Vol. 54, pp. 166-172
Closed Access | Times Cited: 41
Turning genome-wide association study findings into opportunities for drug repositioning
Alexandria Lau, Hon‐Cheong So
Computational and Structural Biotechnology Journal (2020) Vol. 18, pp. 1639-1650
Open Access | Times Cited: 34
Drug Repurposing: A Strategy for Discovering Inhibitors against Emerging Viral Infections
Igor José dos Santos Nascimento, Thiago Mendonça de Aquino, Edeildo Ferreira da Silva‐Júnior
Current Medicinal Chemistry (2020) Vol. 28, Iss. 15, pp. 2887-2942
Closed Access | Times Cited: 32
The Genetic Basis of Hypertriglyceridemia
Germán D. Carrasquilla, Malene Revsbech Christiansen, Tuomas O. Kilpeläinen
Current Atherosclerosis Reports (2021) Vol. 23, Iss. 8
Open Access | Times Cited: 28
Single-cell network biology characterizes cell type gene regulation for drug repurposing and phenotype prediction in Alzheimer’s disease
Chirag Gupta, Jielin Xu, Ting Jin, et al.
PLoS Computational Biology (2022) Vol. 18, Iss. 7, pp. e1010287-e1010287
Open Access | Times Cited: 19
Drug re‐engineering and repurposing: A significant and rapid approach to tuberculosis drug discovery
Dinesh S. Reddy, Anamika Sinha, Amit Kumar, et al.
Archiv der Pharmazie (2022) Vol. 355, Iss. 11
Closed Access | Times Cited: 16
Current trends in natural products for the treatment and management of dementia: Computational to clinical studies
Rajeev K. Singla, Shikha Joon, Baivab Sinha, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 147, pp. 105106-105106
Closed Access | Times Cited: 9
Evaluation of drug repositioning by molecular docking of pharmaceutical resources available in the Brazilian healthcare system against SARS-CoV-2
Matheus V. Coste Grahl, Allan Marinho Alcará, Ana Paula A. Perin, et al.
Informatics in Medicine Unlocked (2021) Vol. 23, pp. 100539-100539
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top